TITLE

Inhaled corticosteroids reduce neutrophilic bronchial inflammation in patients with chronic obstructive pulmonary disease

AUTHOR(S)
Confalonieri, Marco; Mainardi, Elsa; Della Porta, Rossana; Bernorio, Sergio; Gandola, Luciano; Beghé, Bianca; Spanevello, Antonio
PUB. DATE
July 1998
SOURCE
Thorax;Jul1998, Vol. 53 Issue 7, p583
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
No abstract available.
ACCESSION #
67206319

 

Related Articles

  • Inhaled corticosteroids increase pneumonia risk in COPD.  // Reactions Weekly;12/6/2008, Issue 1231, p1 

    The article presents a study which analyzed the effect of inhaled corticosteroids in patients with stable chronic obstructive pulmonary disease (COPD). The study included three types of inhaled corticosteroid: budesonide, fluticasone, and triamcinolone. The study found that inhaled...

  • Inhaled corticosteroids worth it in patients with severe COPD.  // PharmacoEconomics & Outcomes News;5/8/2004, Issue 452, p9 

    Deals with the findings of a study regarding the use of inhaled corticosteroids among patients with chronic obstructive pulmonary disease. Cost effectiveness of inhaled corticosteroids; Mortality benefit of inhaled corticosteroids.

  • Inhaled Steroids Increase Risk of TB in COPD Patients.  // Clinical Cardiology Alert;Jun2013 Clinical Briefs in Primary Care, p12 

    The article focuses on inhaled corticosteroids (ICS) were the use of these steroids leads to increase the risk of pulmonary tuberculosis (TB) in patients with chronic obstructive pulmonary disease (COPD).

  • When to use and when not to use inhaled corticosteroids in COPD. Antón, Esther; Miravitlles, Marc // Hot Topics in Respiratory Medicine;2013, Issue 24, p13 

    The role of inhaled corticosteroids (ICS) in chronic obstructive pulmonary disease (COPD) management is still controversial. There is widespread use of ICS in COPD patients probably because this disease is characterized by airway inflammation, as well as the evident therapeutic benefits of ICS...

  • Review: inhaled corticosteroids do not reduce mortality but increase pneumonia in COPD. Rees, P. John // Evidence Based Medicine;Jun2009, Vol. 14 Issue 3, p8 

    The article offers information on the advantages and disadvantages of inhaled corticosteroid (ICS) therapy in treating patients with stable chronic obstructive pulmonary disease (COPD). It notes that inhaled cortecosteroids with placebo or inhaled medications can contribute to mortality,...

  • Does Inhaled Budesonide Produce Benefits in COPD? Walling, Anne D. // American Family Physician;11/1/1999, Vol. 60 Issue 7, p2156 

    Presents an evaluation on the treatment of chronic obstructive pulmonary disease (COPD) by inhaled corticosteroids. Long-term effects of inhaled budesonide in patients with COPD; Need for differentiation between asthma and COPD in patients with pulmonary symptoms.

  • Corticosteroid-associated risk of pneumonia: EMA review initiated.  // Reactions Weekly;May2015, Vol. 1552 Issue 1, p3 

    The article discusses the European Medicines Agency's (EMA) review of the risk of pneumonia in chronic obstructive pulmonary disease (COPD) patients who received treatment with inhaled corticosteroids.

  • Inhaled corticosteroids and COPD. Farquhar, Donald // CMAJ: Canadian Medical Association Journal;8/08/2000, Vol. 163 Issue 3, p326 

    Reports on a study of the effect of inhaled corticosteroid therapy as a treatment for chronic obstructive pulmonary disease (COPD). Use of the therapy on patients with asthma; Design; Results; Practice implications.

  • Inhaled corticosteroids and mortality in COPD: are we there yet? Stirling, R. // Thorax;Aug2006, Vol. 61 Issue 8, p735 

    A letter to the editor is presented in response to the article on inhaled corticosteroids among patients diagnosed with chronic obstructive pulmonary disease published on the previous issue of the journal.

  • Inhaled Steroids Increase Risk of TB in COPD Patients.  // Critical Care Alert;Jun2013 Clinical Briefs in Primary Care, p12 

    The article reports the association of inhaled corticosteroids (ICS) with risk for development or reactivation of tuberculosis (TB) in chronic obstructive pulmonary disease (COPD) patients.

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sign out of this library

Other Topics